Albert Parés
- Hepatology top 0.05%
- Liver Diseases and Immunity 134
- Liver Disease and Transplantation 32
- Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment 141
- Pharmacology top 0.2%
- Surgery top 0.5%
- Pediatric Hepatobiliary Diseases and Treatments 52
-
- Alcohol Consumption and Health Effects 37
-
- Drug Transport and Resistance Mechanisms 22
- Bone health and treatments 16
-
- Gallbladder and Bile Duct Disorders 17
- Co-authors
- Joan RodésLlorenç CaballeríaJoan CaballeríaJuan RodésNúria GuañabensMiquel BrugueraPilar PerisKirsten Muri Boberg
- Cited by
- HepatologyEpidemiologyPharmacology
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Albert Parés
255 papers receiving 11.6k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Hepatology 7.7k
- Epidemiology 7.2k
- Pharmacology 802
- Surgery 3.7k
- Orthopedics and Sports Medicine 695
Countries citing papers authored by Albert Parés
This map shows the geographic impact of Albert Parés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Parés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Parés more than expected).
Fields of papers citing papers by Albert Parés
This network shows the impact of papers produced by Albert Parés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Parés. The network helps show where Albert Parés may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Albert Parés, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 11 | |
| 2 | 2021 | 125 | |
| 3 | 2019 | 11 | |
| 4 | 2019 | 19 | |
| 5 | 2012 | 15 | |
| 6 | 2011 | 47 | |
| 7 | The first new monotherapy therapeutic PBC study in a decade? An international study evaluating the faresoid C receptor agonist obeticholic acid in PBC | 2011 | 6 |
| 8 | 2011 | 13 | |
| 9 | 2010 | 2 | |
| 10 | 2010 | 2 | |
| 11 | Tratamiento de la hepatitis alcohólica | 2007 | 0 |
| 12 | Alcohol y aparato digestivo | 2006 | 1 |
| 13 | 2004 | 15 | |
| 14 | 2003 | 144 | |
| 15 | 2001 | 1 | |
| 16 | Ictericia y colestasis | 2000 | 1 |
| 17 | 1999 | 1 | |
| 18 | HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups. | 1998 | 1 |
| 19 | Prognostic indicators of primary sclerosing cholangitis determined by a cox phase-specific time-dependent model. | 1998 | 1 |
| 20 | 1996 | 26 |
About Albert Parés
Albert Parés is a scholar working on Hepatology, Epidemiology, Pathology and Forensic Medicine, Orthopedics and Sports Medicine and Surgery, having authored 266 papers that have together received 11.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (141 papers), Liver Diseases and Immunity (134 papers), Pediatric Hepatobiliary Diseases and Treatments (52 papers), Alcohol Consumption and Health Effects (37 papers), Liver Disease and Transplantation (32 papers), Drug Transport and Resistance Mechanisms (22 papers), Gallbladder and Bile Duct Disorders (17 papers) and Bone health and treatments (16 papers). The work is most often cited by research in Hepatology (7.7k citations), Epidemiology (7.2k citations), Pharmacology (802 citations), Surgery (3.7k citations) and Orthopedics and Sports Medicine (695 citations). Albert Parés has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Joan Rodés, Llorenç Caballería, Joan Caballería, Juan Rodés, Núria Guañabens, Miquel Bruguera, Pilar Peris, Kirsten Muri Boberg, J Rodés and Keith D. Lindor. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, The American Journal of Gastroenterology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.